Healio

Etripamil reduces ventricular rate in patients with AF

Please provide your email address to receive an email when new articles are posted on . Etripamil reduced ventricular rate in patients with atrial fibrillation and rapid ventricular rate compared with ...
TCTMD

Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate

PHILADELPHIA, PA—Etripamil nasal spray (Milestone Pharmaceuticals) appears to provide quick relief for patients with atrial fibrillation (AF) accompanied by a rapid ventricular rate, according to ...
WDAF-TV

Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of Atrial Fibrillation with Rapid Ventricular Rate

MONTREAL and CHARLOTTE, N.C., May 8, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative ...
WHNT

Milestone Pharmaceuticals Announces Presentation of Data from Analysis of Etripamil Nasal Spray in Patients Experiencing Atrial Fibrillation with Rapid Ventricular Rate

- Self-administration of etripamil in patients experiencing AFib-RVR episodes resulted in a substantial reduction in ventricular rate which was sustained over 60 minutes - Data featured in an oral ...
WebMD

Heart Rate Control for Atrial Fibrillation

What Is Rate Control for Atrial Fibrillation? Rate control is not a cure for AFib, but a way of keeping your heart rate in check. It’s done with medications that keep your heart from beating too ...
WRBL

Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of Atrial Fibrillation with Rapid Ventricular Rate

To access a live or recorded webcast of the event and accompanying slides, please visit the News & Events section of Milestone's website at www.milestonepharma.com. To access the live call by phone, ...